Egypt vs Jordan: HIV-positive TB patients on ART (antiretroviral therapy)
Egypt
100.0%
in 2024
Jordan
100.0%
in 2024
Egypt rank
1st
Jordan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Egypt
- Jordan
How they compare
Egypt currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
Across all 6 years both countries report, Jordan has been ahead every year.
Egypt ranks 1st and Jordan ranks 1st of 144 countries.
Head to head by decade
| Decade | Egypt | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Egypt or Jordan?
- Egypt, at 100.0% against 100.0% in Jordan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Egypt and Jordan?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Jordan?
- 6 years are reported by both, from 2007 to 2024.
- How do Egypt and Jordan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Egypt ranks 1st and Jordan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.